Plain-English translation of NCT06482489 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Researchers are testing whether a newer, smaller MRI machine (0.55T) can detect prostate cancer as accurately as the standard, more powerful MRI machine (3T) currently used in hospitals. This study has three stages: first, they'll optimize the new machine's settings using healthy volunteers; second, they'll test it in men with metal hip implants to see if it produces clearer images; and third, they'll test it in men who already have suspicious findings on a standard MRI to see if it can help guide biopsy decisions.
Standard MRI machines are expensive and not available everywhere, which makes prostate cancer screening difficult for many men. Additionally, metal implants like hip replacements can create fuzzy images on standard machines. This trial tests whether a smaller, more affordable MRI machine could make screening more accessible while still catching cancer accurately.
You likely qualify if…
You likely don't qualify if…
Your involvement depends on which group you join. If you're a healthy volunteer, you'll have one MRI scan on the new machine. If you have a metal implant or a suspicious finding on a previous MRI, you'll have scans on both the new machine and the standard machine so doctors can compare the image quality. The entire process involves lying still inside the MRI machine while it takes pictures of your prostate—each scan typically takes 30–45 minutes.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Switzerland
Sponsor
University of Lausanne Hospitals
Enrollment target
~74 participants
Started
November 2024
Primary completion
May 2027
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Naïk Vietti-Violi, Dre
University of Lausanne Hospitals
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.